Home
Finance & valuation

Finance & valuation

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

Delaware Judge’s litigation finance disclosure may harm plaintiffs, lead to defence settlements

Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand

Dealing with 5G disappointment

The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations

Latest content

Under sanctions pressure, Huawei sells off entry level smartphone brand to government

Company has sold its Honor handset unit to a consortium backed by local authorities in Shenzhen government, a move that will take a big chunk out of its sales figures

17 November 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation

10 November 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome

09 November 2020

Meet the IV veteran creating an IP licensing business in the pharma space

Connie Wan of Seattle Gummy Company talks to IAM about the lessons she learned at the mega-NPE

06 November 2020

Elite patent stocks fell in September but outperformed NASDAQ

The composite stock performance of the IAM/ktMINE US Patent Elite dipped though not by as much as most major exchanges

05 November 2020

IBM’s LaFontaine takes top spot in this year’s IAM Market Makers ranking

On the back of 12 months of ferocious dealmaking, Big Blue’s IP head sits at number one in the annual list

04 November 2020

CEO’s patent comments illustrate high stakes of LG Chem IP campaign

The company plans to spin off its lucrative auto battery business, and executive says patents will be key to fending off competition from China

04 November 2020

The brokered patent market in 2020

Featured in Secondary Market Activity

As a drop in corporate buying is matched by a rise in NPE activity, it is time to keep your friends close and your defensive aggregators closer

04 November 2020

Lions of global patent dealmaking revealed

IP leaders from the likes of Panasonic, InterDigital, Broadcom and Microsoft sit in places 20 to 11 of this year’s IAM Market Makers ranking

03 November 2020

Leaders of the world’s patent deals pack

The countdown of this year's IAM Market Makers - our annual ranking of the 40 most influential players in the global IP market - begins today with places 40 to 21

02 November 2020

Get unlimited access to all IAM content